RNF130 Protects Against Pulmonary Fibrosis Through Suppressing Aerobic Glycolysis by Mediating C-Myc Ubiquitination.
Jinming Zhang,Weimou Chen,Jiangzhou Du,Lanhe Chu,Zili Zhou,Wenshan Zhong,Dongyu Liu,Haohua Huang,Yi Huang,Yujie Qiao,Xiaojing Meng,Fei Zou,Shaoxi Cai,Hangming Dong
DOI: https://doi.org/10.1016/j.intimp.2023.109985
IF: 5.714
2023-01-01
International Immunopharmacology
Abstract:Background: Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal disease,characterized by an excessive accumulation of extracellular matrix (ECM) proteins in response to chronic lung injury. Current evidence sug-gests that metabolic reprogramming is always accompanied by myofibroblast activation in IPF of which the underlying mechanisms remain unclear. Ring finger protein 130 (RNF130), was demonstrated involved in multiple diseases. However, whether RNF130 plays a critical role in the pathogenesis of IPF needs to be clarified.Methods: We first investigated the expression of RNF130 in pulmonary fibrosis in vivo and in vitro. We then observed the effect and explored the molecular mechanism of RNF130 on the transition of fibroblast to myofi-broblast and aerobic glycolysis. Further, we assessed the effects of adeno-associated virus (AAV)-induced RNF130 overexpression in the pulmonary fibrosis model, conducting pulmonary function, assessment of collagen deposition using the hydroxyproline assay, and biochemical and histopathological analyses.Results: We found that RNF130 was down-regulated in lung tissues of mice with bleomycin-induced pulmonary fibrosis and lung fibroblasts treated with transforming growth factor-beta 1 (TGF-beta 1). Then we demonstrated that RNF130 inhibited the transition of fibroblast to myofibroblast by suppressing aerobic glycolysis. Mechanistically, we revealed that RNF130 promoted c-myc ubiquitination and degradation, while c-myc overexpression reverses the inhibitory effects of RNF130. Importantly, pulmonary function, collagen deposition and fibroblast differ-entiation were significantly alleviated in adeno-associated virus serotype (AAV)6-RNF130 treated mice, which further validated the contribution of RNF130/c-myc signaling axis in pulmonary fibrosis pathological process.Conclusions: In summary, RNF130 participates in the pathogenesis of pulmonary fibrosis by inhibiting the transition of fibroblast to myofibroblast and aerobic glycolysis through promoting c-myc ubiquitination and degradation. Targeting RNF130-c-myc axis might represent a promising strategy to alleviate the progression of IPF.